|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on May 03, 2018 |
Title |
T3 FFPE mRNA-seq (500ng) |
Sample type |
SRA |
|
|
Source name |
breast cancer tumor sample
|
Organism |
Homo sapiens |
Characteristics |
tissue: breast cancer tumor sample sample_type: FFPE protocol: mRNA-seq starting material (ng): 500 patient: T3 archival time: 4-5 years
|
Extracted molecule |
total RNA |
Extraction protocol |
FFPE tumor samples were sectioned to 5 micron slices and deparafinized at 90°C for 5 min. Total RNA was extracted using nucleic acid isolation kit (AllPrep® Qiagen) according to the protocol instructions, with the following modifications: DNAse treatment was at 37° for 20 minutes and the column was incubated for 1 min before each washing step with buffer RPE. Samples were eluted in 30 μL purified water. RNA from FF tumor samples was extracted using Trizol. RNA concentrations were determined by Qubit™ fluorometer (Thermofisher scientific) and the RNA quality was determined by measuring the RNA integrity number (RIN) using Agilent TapeStation. Total RNA from FFPE and FF samples was processed using two protocols: 1. Truseq RNA Sample preparation kit v2 (illumina) (cat# RS-122-2002) for mRNA-seq libraries. Briefly, polyA fraction (mRNA) was purified from 500ng or 100ng of total RNA following by fragmentation and generation of double stranded cDNA. Then, end repair, A base addition, adapter ligation and PCR amplification steps were performed. 2. Truseq Stranded total RNA with Ribo-Zero Gold. Library Protocol: TruSeq® Stranded Total RNA (Illumina) (Cat # RS-122-2301, RS-122-2302) for ribosomal-depletion libraries. Briefly, After rRNA depletion from 500ng total RNA with rRNA Ribo-Zero Gold removal mix, cDNA was performed followed by second strand synthesis with dUTP instead of dTTP. Then, A base addition, adapter ligation, UDG treatment and PCR amplification steps were performed
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 2500 |
|
|
Data processing |
Fragments were mapped to the human genome (hg19) using TopHat version V2.0.5 Only uniquely mapped fragments to the genome were considered and exonic and intronic signals were calculated using HTSeq The signals of the same sample from all lanes were summed The number of fragments obtained for each gene in each sample was normalized to the total number of fragments obtained from this sample The minimum expression level threshold was set to 5 (log2 scale) to reduce noise (based on data distribution). Genome_build: hg19 Supplementary_files_format_and_content: tab-delimited text files include normalized number of reads (log2 scale) for each sample
|
|
|
Submission date |
May 02, 2018 |
Last update date |
May 04, 2018 |
Contact name |
Noa Bossel Ben-Moshe |
Organization name |
Weizmann
|
Street address |
Hertzl Street
|
City |
Rehovot |
ZIP/Postal code |
76100 |
Country |
Israel |
|
|
Platform ID |
GPL16791 |
Series (1) |
GSE113976 |
mRNA-seq Whole Transcriptome Profiling of Fresh Frozen versus Archived Fixed Tissues |
|
Relations |
BioSample |
SAMN09015083 |
SRA |
SRX4024020 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|